Frontlight ResearchEarly access
Haemophilia trials in France
11 of 26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleDevelopment of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
- Where
- Paris
- Age
- 18 years and over
- People
- 550
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06147414 - No phaseTaking peopleDeterminants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project
- Where
- Annecy, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille, Montmorency, Montpellier, Nancy, Nantes, Paris, Reims, Rennes, Rouen, Saint-Denis, Saint-Etienne, Strasbourg, Toulouse, Versailles
- Age
- 20 years to 29 years
- People
- 75
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT07418827 - No phaseNot yet taking people in FranceEfanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A
- Where
- Angers, Bordeaux, Brest, Caen, Chambray-lès-Tours, Le Mans, Nantes, Rennes
- People
- 553
- Run by
- Nantes University Hospital
See details and how to joinNCT07830693 - No phaseTaking peopleStudy of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)
- Where
- Bron
- People
- 160
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07723560 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Besançon, Chambéry, Chambray-lès-Tours, Le Mans, Montmorency, Nantes, Paris, Saint-Priest-en-Jarez
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - No phaseTaking peopleSevere Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
- Where
- Lille
- Age
- 18 years and over
- People
- 200
- Run by
- University Hospital, Lille
See details and how to joinNCT06090201 - No phaseTaking peopleMonitoring of Anti-TFPI in Hemophilia
- Where
- Bron, Paris
- Age
- 18 years and over
- People
- 11
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07101926 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Brest, Nantes, Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - Phase 4CompletedA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Lille, Marseille
- Age
- 18 years and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - No phaseTaking peopleLong-term Anticoagulation in a Patient With Severe Hemophilia A
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 1
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07314983 - No phaseTaking peopleThe European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Le Kremlin-Bicêtre, Marseille Cedex-05, Toulouse
- People
- 4,000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119